Nurix Therapeutics, Inc. (NRIX) Financials

NRIX Assets vs Liabilities

DateAssetsLiabilities
2024-02-29 312.7 million 143.9 million
2023-11-30 364.5 million 164.0 million
2023-08-31 308.2 million 74.4 million
2023-05-31 350.6 million 90.7 million

NRIX Free Cash Flow and Stock based compensation

Graph available only for supporters. Become a supporter to see it.
DateFree Cash FlowStock based compensation
2024-02-29 -44.8 million 7.8 million
2023-11-30 19.2 million 8.0 million
2023-08-31 -43.6 million 8.4 million
2023-05-31 -19.5 million 8.7 million

NRIX Net Income

No data available :(

NRIX Cash and Debt

Graph available only for supporters. Become a supporter to see it.
DateCashDebtCapital Lease
2024-02-29 244.0 million - 29.2 million
2023-11-30 287.9 million - 30.6 million
2023-08-31 258.9 million - 8.0 million
2023-05-31 281.2 million - 9.3 million

NRIX Shares Outstanding

Graph available only for supporters. Become a supporter to see it.
DateShares Outstanding
2024-02-29 54.9 million
2023-11-30 54.7 million
2023-08-31 54.4 million
2023-05-31 54.3 million

NRIX Expenses

Graph available only for supporters. Become a supporter to see it.
DateCapexR&DG&AS&M
2024-02-29 2.9 million 48.0 million 11.8 million 1.8 million
2023-11-30 2.6 million 47.8 million 10.8 million 1.8 million
2023-08-31 2.5 million 47.9 million 10.6 million -
2023-05-31 1.1 million 45.8 million 11.7 million -

NRIX Cost of Revenue

Graph available only for supporters. Become a supporter to see it.
DateRevenueCost of Revenue
2024-02-29 16.6 million 3.9 million
2023-11-30 15.2 million 3.8 million
2023-08-31 18.5 million 3.4 million
2023-05-31 30.7 million 3.3 million

NRIX

Price: $12.78

52 week price:
4.22
18.12

Earnings Per Share: -2.65 USD

P/E Ratio: -2.97

Exchange: NGM

Sector: Healthcare

Industry: Biotechnology

Volume: 161700

Market Capitalization: 720.1 million

Links: